Test Price
2,800 AED✅ Home Collection Available
HIV-1 Genotyping & Drug Resistance Test (Reverse Transcriptase PCR & DNA Sequencing) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل فيروس نقص المناعة البشرية (HIV-1) للتنميط الجيني ومقاومة الأدوية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Clinical Confidence, Local Compliance
- 99.9% Diagnostic Sensitivity – ISO-accredited processing ensures reliable HIV-1 resistance profiles.
- Hospital‑Grade Home Collection – VIP mobile phlebotomy with cold‑chain logistics for sample integrity.
- Telephonic Post‑Test Guidance – direct interpretation support from our clinical team.
- Insurance Verification – submit your details via WhatsApp +971 54 548 8731 for direct billing.
الفحص التنميط الجيني لمقاومة فيروس HIV-1 للأدوية
يضمن هذا الفحص الدقيق بنسبة 99.9% تشخيص مقاومة فيروس HIV-1 للأدوية وفق أعلى معايير هيئة الصحة بدبي، مع سحب منزلي آمن واستشارات طبية معتمدة.
Test Overview
The HIV-1 Genotyping & Drug Resistance Test identifies mutations in the viral protease, reverse transcriptase, and integrase genes using Sanger sequencing, guiding selection of active antiretroviral therapy (ART). This test is critical for patients with virologic failure or before treatment initiation in the UAE, processed in batches to ensure cost efficiency without compromising accuracy.
| Feature | Our Test (AMERICAN BOARD CERTIFIED) | Closest Alternative (Standard Lab) |
|---|---|---|
| Methodology | Reverse Transcriptase PCR + Sanger Sequencing (gold‑standard) | Commercial line probe assay (LiPA) – limited to common mutations |
| Report Turnaround | 15th or 30th of each month (batch‑processed) | 7–14 working days (less comprehensive) |
| Interpretation | Full clinical interpretation with resistance scores (Stanford HIVdb), DHA‑compliant | Raw mutation list – requires external consult |
| Regulatory Adherence | Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 compliant | Not explicitly audited for UAE legal frameworks |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY
DHA License: 61713011 • Consultant Clinical Pathology
"HIV-1 genotypic resistance testing provides a roadmap for therapy, but clinical correlation with viral load, adherence history, and comorbidities is essential. This assay has helped many UAE patients salvage failing regimens when interpreted with expert judgement. Always involve an HIV specialist before changing any antiretroviral drug."
Critical Safety Notice
Do not discontinue or modify prescribed antiretroviral medication without consulting your treating physician.
- Exclusion Criteria (Do NOT schedule): Known active bleeding disorder; inability to provide 2 mL plasma; sample not frozen within 6 hours.
- ER Red Flags: If you experience severe rash, jaundice, or signs of lactic acidosis (unexplained fatigue, abdominal pain, rapid breathing), seek emergency care immediately—these may indicate ART toxicity unrelated to the test.
- Sample Integrity: The specimen must be separated, transferred to a plastic vial, and frozen immediately. Once thawed, the sample is discarded and redraw required.
Pre‑test Information & Logistics
No special patient preparation (fasting not required). However, the sample must be collected in a Lavender Top (EDTA) tube, plasma separated within 6 hours, transferred to a plastic transport vial, and frozen immediately. Ship frozen. Do not thaw. All home collection services are conducted by DHA‑licensed phlebotomists following cold‑chain standards.
Frequently Asked Questions
1. What does the HIV‑1 Genotyping & Drug Resistance Test detect?
This test identifies specific mutations in the HIV-1 protease, reverse transcriptase, and integrase genes that confer resistance to antiretroviral drugs, guiding personalized therapy selection. Our Sanger sequencing approach covers all clinically relevant regions, and the report is aligned with the Stanford HIV Drug Resistance Database for UAE clinicians.
يكشف هذا الفحص عن طفرات جينية في إنزيمات البروتياز والمنتسخة العكسية والإنزيم المدمج لفيروس HIV-1، مما يساعد في اختيار العلاج المضاد للفيروسات القهقرية المناسب لكل مريض.
2. When will I receive the test results, and how are they reported?
Results are available on the 15th or the 30th of each month, depending on the sample receipt date, and are delivered as a secure digital report with clinical interpretation. The report includes a list of detected mutations, drug susceptibility scores, and a UAE‑specific recommendation tier. Our clinical team can arrange a telephone consultation to walk you through the findings.
تظهر النتائج في اليوم الخامس عشر أو الثلاثين من كل شهر، وتُقدم عبر تقرير رقمي آمن يتضمن تفسيراً سريرياً ودعماً استشارياً هاتفياً.
3. Is home sample collection safe and approved for this?
Yes, our home collection service operated by DHA‑licensed nurses adheres to cold‑chain protocols and ISO 9001:2015 standards, maintaining sample viability for accurate resistance testing. The phlebotomist will centrifuge the EDTA tube on‑site, aliquot the plasma into a freeze‑safe vial, and place it immediately in a validated frozen shipper. This eliminates any risk of thawing and ensures the highest diagnostic accuracy.
نعم، خدمة السحب المنزلي مرخصة من هيئة الصحة بدبي وتلتزم بمعايير سلسلة التبريد لنقل العينة بشكل آمن لضمان دقة التحليل.
Regulatory Compliance: Federal Decree‑Law No. 41 of 2024 on the Protection of Health Data and Confidentiality (Article 87); UAE Personal Data Protection Law (PDPL); CDS Law 2026 (Minors Consent). ISO 9001:2015 Certification No. INT/EGQ/2509DA/3139. All clinical content reviewed by Dr. Prabhakar Reddy, DHA License 61713011.
Contact: +971 54 548 8731 (WhatsApp) • UAE Ministry of Health & Prevention licensed facility 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians